Company Overview of Mendel Biotechnology, Inc.
Mendel Biotechnology, Inc. operates as a plant biotechnology company. The company focuses on developing genetic and chemical solutions for a range of agricultural markets. It offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company has strategic partnerships with Monsanto Corporation, BP, and Bayer CropScience. Mendel Biotechnology, Inc. was founded in 1997 and is based in Hayward, California. It has operations in the United States, Europe, and China.
3935 Point Eden Way
Hayward, CA 94545-3720
Founded in 1997
Key Executives for Mendel Biotechnology, Inc.
Senior Vice President of BioEnergy Seeds
Vice President of Human Resources
Compensation as of Fiscal Year 2014.
Mendel Biotechnology, Inc. Key Developments
Mendel Biotechnology Mulls Sale Of Subsidiary
Sep 4 13
Mendel Biotechnology, Inc. announced its intention to sell its operating subsidiary Mendel Plant Sciences. Mendel Biotechnology has engaged Kirchner Group to advise the Board and lead the acquisition process. "The Board of Directors feels that the Company can best achieve its full potential within the context of a larger organization that has a complementary strategic focus. In this way, it could fully realize its commercial opportunities within the billion-dollar markets that its platform creates," explained Neal Gutterson, President and Chief Executive Officer of Mendel Biotechnology.
Mendel Biotechnology, Inc. and Fundacion MEDINA Enter into a License Collaboration
Jul 23 13
Mendel Biotechnology, Inc. and Fundacion MEDINA have entered into a license collaboration that will enable Mendel to identify novel biostimulant products. Biostimulants are a new category of agricultural chemicals derived from natural sources and applied as seed treatments or foliar applications to improve crop productivity through improved stress tolerance, water and nutrient use efficiency, and overall growth and yield. These natural products can be brought to the market more quickly and with lower regulatory costs than synthetic chemistries. Under the agreement, MEDINA will provide Mendel with microbial extracts from elite culture collections. Mendel will run its proprietary screens on these collections to identify natural products with crop performance benefits. Those that enhance drought tolerance and increase yield are targeted as the first products from these screens.
E. I. du Pont de Nemours and Company Signs Pact with Mendel Biotechnology, Inc. to Develop Water-Efficient Corn Trait
Mar 18 13
E. I. du Pont de Nemours and Company's Pioneer seed unit and Mendel Biotechnology, Inc. have entered into a license collaboration to evaluate and commercialize new gene leads for increased water-use efficiency and improved photosynthesis in corn. Under the agreement, the two companies will evaluate new gene leads and test them for yield-enhancement traits in Pioneer-brand corn products. The gene leads were identified by Mendel in its plant physiology platform.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|